Swiss National Bank
MCRB icon

Swiss National Bank’s Seres Therapeutics MCRB Stock Holding History

Swiss National Bank’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-11,250
Closed -$536K – 2581
2023
Q3 		$536K Buy
11,250
+270
+2% +$20.6K ﹤0.01% 2499
2023
Q2 		$1.05M Buy
10,980
+225
+2% +$24.5K ﹤0.01% 2264
2023
Q1 		$1.22M Sell
10,755
-1,230
-10% -$133K ﹤0.01% 2135
2022
Q4 		$1.34M Buy
11,985
+345
+3% +$46.3K ﹤0.01% 2157
2022
Q3 		$1.5M Buy
11,640
+4,070
+54% +$417K ﹤0.01% 2074
2022
Q2 		$519K Sell
7,570
-575
-7% -$49.5K ﹤0.01% 2602
2022
Q1 		$1.16M Buy
8,145
+605
+8% +$93.1K ﹤0.01% 2335
2021
Q4 		$1.26M Hold
7,540
– – ﹤0.01% 2340
2021
Q3 		$1.05M Hold
7,540
– – ﹤0.01% 2419
2021
Q2 		$3.6M Buy
7,540
+245
+3% +$103K ﹤0.01% 1724
2021
Q1 		$3M Buy
7,295
+355
+5% +$163K ﹤0.01% 1754
2020
Q4 		$3.4M Buy
+6,940
New +$4.06M ﹤0.01% 1605
2019
Q2 		– Sell
-1,805
Closed -$248K – 2561
2019
Q1 		$248K Hold
1,805
– – ﹤0.01% 2481
2018
Q4 		$163K Buy
1,805
+125
+7% +$17.5K ﹤0.01% 2528
2018
Q3 		$255K Hold
1,680
– – ﹤0.01% 2492
2018
Q2 		$289K Hold
1,680
– – ﹤0.01% 2514
2018
Q1 		$247K Hold
1,680
– – ﹤0.01% 2469
2017
Q4 		$341K Hold
1,680
– – ﹤0.01% 2479
2017
Q3 		$539K Hold
1,680
– – ﹤0.01% 2356
2017
Q2 		$380K Buy
1,680
+495
+42% +$102K ﹤0.01% 2476
2017
Q1 		$267K Hold
1,185
– – ﹤0.01% 2497
2016
Q4 		$235K Hold
1,185
– – ﹤0.01% 2539
2016
Q3 		$291K Hold
1,185
– – ﹤0.01% 2492
2016
Q2 		$688K Buy
1,185
+515
+77% +$302K ﹤0.01% 2180
2016
Q1 		$341K Buy
670
+160
+31% +$83.5K ﹤0.01% 2457
2015
Q4 		$358K Buy
+510
New +$335K ﹤0.01% 2419

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Swiss National Bank's MCRB Position: Q4 2023 in Review

Swiss National Bank sold out of Seres Therapeutics (MCRB) in Q4 2023, closing a stake of 11,250 shares — an estimated $536K sold.

Swiss National Bank first reported a position in MCRB in Q4 2015 and held it in 26 quarters. The position peaked at $3.6M in Q2 2021. 102 funds tracked by Wall St. Rank hold MCRB as of Q4 2023.

  • Swiss National Bank reported no remaining Seres Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Swiss National Bank sold 11,250 Seres Therapeutics shares in Q4 2023, an estimated $536K.
  • Swiss National Bank first reported a position in Seres Therapeutics in Q4 2015 and held it in 26 quarters.
  • Swiss National Bank's Seres Therapeutics position peaked at $3.6M in Q2 2021.
  • 102 funds tracked by Wall St. Rank held Seres Therapeutics as of Q4 2023.

Based on Swiss National Bank's 13F filing for Q4 2023, filed 6 Feb 2024.